{"brief_title": "Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)", "brief_summary": "A multicenter trial to assess the safety and efficacy of an investigational drug in the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with confirmed solid tumors who will be treated with a chemotherapy regimen that includes cisplatin. The study will evaluate the investigational drug for the treatment of CINV during the first cycle of treatment with cisplatin.", "condition": ["Nausea", "Vomiting"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["MK0869, aprepitant / Duration of Treatment: 3 days", "Comparator: ondansetron / Duration of Treatment: 4 days"], "criteria": "Inclusion Criteria: - Patient is greater than 18 years of age. - Patient is scheduled to receive his/her first course of cisplatin chemotherapy for a solid tumor. - Patient has a prognosis (life expectancy) greater than or equal to 3 months.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Nausea", "Vomiting", "Aprepitant", "Fosaprepitant", "Ondansetron"], "id": "NCT00090207"}